JA
DVAX

JVL Associates’s Dynavax Technologies DVAX Stock Holding History

JVL Associates’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,125
Closed -$289K – 66
2025
Q2 		$289K Sell
29,125
-62
-0.2% -$653 0.1% 51
2025
Q1 		$379K Buy
29,187
+9
+0% +$119 0.15% 44
2024
Q4 		$373K Sell
29,178
-20
-0.1% -$242 0.14% 43
2024
Q3 		$325K Buy
29,198
+49
+0.2% +$540 0.13% 43
2024
Q2 		$327K Buy
29,149
+32
+0.1% +$372 0.13% 40
2024
Q1 		$361K Sell
29,117
-25
-0.1% -$326 0.15% 42
2023
Q4 		$407K Sell
29,142
-7,149
-20% -$99.3K 0.18% 34
2023
Q3 		$536K Hold
36,291
– – 0.28% 28
2023
Q2 		$469K Buy
36,291
+41
+0.1% +$467 0.23% 28
2023
Q1 		$356K Sell
36,250
-22
-0.1% -$235 0.19% 30
2022
Q4 		$386K Sell
36,272
-8,749
-19% -$102K 0.22% 28
2022
Q3 		$470K Sell
45,021
-35
-0.1% -$456 0.28% 32
2022
Q2 		$567K Buy
+45,056
New +$479K 0.39% 24

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

JVL Associates's DVAX Position: Q3 2025 in Review

JVL Associates sold out of Dynavax Technologies (DVAX) in Q3 2025, closing a stake of 29,125 shares — an estimated $289K sold.

JVL Associates first reported a position in DVAX in Q2 2022 and held it in 13 quarters. The position peaked at $567K in Q2 2022. 270 funds tracked by Wall St. Rank hold DVAX as of Q3 2025.

  • JVL Associates reported no remaining Dynavax Technologies position as of Q3 2025 after selling out during the quarter.
  • JVL Associates sold 29,125 Dynavax Technologies shares in Q3 2025, an estimated $289K.
  • JVL Associates first reported a position in Dynavax Technologies in Q2 2022 and held it in 13 quarters.
  • JVL Associates's Dynavax Technologies position peaked at $567K in Q2 2022.
  • 270 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2025.

Based on JVL Associates's 13F filing for Q3 2025, filed 10 Oct 2025.